Tag: NASD:CBUS

Last Friday saw a noteworthy improvement in the stock performance of Cibus, Inc. (NASDAQ: CBUS), with shares ending at $3.70, a 16.72% rise. This increase occurs before the business will showcase its cutting-edge technology at a major industry event.

Finalist for the InnovActor Award at Euroseeds 2024

Cibus has been named a finalist for the prestigious Euroseeds2024 InnovActor Award. At the Euroseeds2024 Congress, which is being held in Copenhagen, Denmark from October 13 to 16, the company’s cutting-edge innovations will be displayed on the InnovAction Stage.

Dr. Jim Radtke, Cibus’s Senior Vice President of Product Development, will give a presentation about the company’s progress. CBUS will be represented at this important occasion by Dr. Radtke, a recent recipient of the American Seed Trade Association’s (ASTA) Lifetime Achievement Award, whose winner is scheduled to be revealed on October 15.

Promoting Innovation in the Seed Sector

Cibus’ exclusive RTDS-based high throughput breeding technology is a major contributor to the innovation that is essential to the advancement of the seed business. Cibus’s leadership in bringing about revolutionary advances in European agriculture is further cemented by Euroseeds’ recognition.

The Euroseeds InnovAction Stage offers a venue to showcase innovations in data-driven decision-making, crop resilience, and contemporary plant breeding—areas where Cibus’ technology is having a big influence.

Enhancing Agricultural Sustainability

Cibus’ RTDS technology solves important agricultural difficulties by speeding up the creation of novel plant characteristics. CBUS increases yield gains, nutrient efficiency, and crop resilience, providing the industry with the means to create more sustainable and productive agricultural systems.

There are a plethora of chances to boost farm output and create a more resilient agri-food system by using RTDS on a variety of crops. This will enable farmers to better manage environmental challenges like climate change.

With its cutting-edge technology solutions that have the potential to transform farming methods and promote global food sustainability, Cibus (CBUS) is a key participant in the accelerated plant breeding market.

Cibus, Inc. (NASDAQ: CBUS) witnessed a notable rise in its stock value, with shares increasing by 9.35% in the latest trading session. This surge brought the CBUS stock to a close at $5.03, following the company’s announcement of the successful completion of a significant field trial.

Cibus Completed Field Trials Successfully

Cibus confirmed the completion of its initial field tests for the Pod Shatter Reduction (PSR) trait in the United Kingdom. The early results from these trials provide substantial support for the continued commercial development of this trait, specifically in winter oilseed rape. These trials are a significant step forward in Cibus’ efforts to expand the application of its spring oilseed rape PSR trait to winter varieties.

Impact of Simplified Regulatory Framework

The UK Department for the Environment, Food and Rural Affairs introduced simplified regulations in 2022, which facilitated a more streamlined, science-based approach to testing. This regulatory adjustment allowed Cibus to trial its PSR trait in winter oilseed rape under European conditions for the first time. This milestone marks a critical development in the company’s journey to enhance crop resilience through gene editing.

CBUS Advancing in Precision Breeding Technologies

Cibus, a pioneer in the creation of intricate gene-edited characteristics, uses its unique Rapid Trait Development System (RTDS). This system includes advanced techniques such as Gene Repair Oligonucleotides (GRON) and molecular scissors like Transcription activator-like effector nucleases (TALENs). The promising results from the initial UK field trials validate the performance of Cibus’ PSR trait under real-world conditions, paving the way for further trials in the upcoming season.

Implications for European Agriculture

Pod shatter in winter oilseed rape poses a significant threat to agricultural productivity, with potential yield losses ranging from 5% to 25%. The success of these initial trials is a pivotal milestone for Cibus, as it works towards delivering the benefits of precision breeding tools to European farmers. The company’s advancements are expected to enhance productivity and contribute positively to food security across the region.